An NHS document confirms that staff members were instructed to give suspected Covid patients midazolam.

Respiratory depressant medications "should not be withheld due to inappropriate concerns" over its use in treating Covid-19 patients, the NHS staff was informed. Official records from the NHS attest

Respiratory depressant medications "should not be withheld due to inappropriate concerns" over its use in treating Covid-19 patients, the NHS staff was informed.

Official records from the NHS attest to the fact that employees were directed to provide patients who claimed to have "Covid"—a respiratory illness that can cause breathing difficulties—midazolam, a medication that poses a life-threatening risk to their health.

According to Expose News, midazolam can result in severe or potentially fatal breathing issues, such as shallow, slowed, or momentarily stopped breathing, which could cause a permanent brain injury or even death. UK regulators advise that midazolam should only be administered in a hospital or doctor's office equipped with the necessary equipment to monitor your heart and lungs and to promptly administer life-saving medical treatment if your breathing slows or stops.

The medication should also be used extremely cautiously in older patients since it is illegally used in palliative care in the United Kingdom even though it is not on the WHO's list of essential medications for palliative care.

Nevertheless, in reaction to the implementation of the first lockdown, Matt Hancock and the Department of Health placed an order for two years' supply of Midazolam in March 2020. a supply lasting two years, which ran out by October of that year.

The reason for this is that the NHS refused to treat the elderly and vulnerable; this was done in accordance with a pandemic response policy that was planned four years in advance. Instead, the patients received end-of-life care, which included taking their medication, denying them food and water, and giving them large doses of morphine and midazolam until they passed away from starvation and dehydration.

Data on out-of-hospital prescribing for midazolam coinciding with waves of all cause deaths and Covid-19 deaths in the UK, as well as the Amnesty and CQC reports that found the blanket use of Do Not Resuscitate orders being used in care homes without informing the residents or their families, all suggest that the drug midazolam was used to prematurely end the lives of thousands upon thousands of people in the UK who you were told had died of Covid-19.

In Covid-19, pneumonia and concomitant respiratory insufficiency are indicative of a serious disease. The following are therefore common symptoms: fever, weakness, coughing, and dyspnea. We are also informed that severe dyspnea associated with acute respiratory distress syndrome occurs in patients with declining respiratory failure who do not get critical care.

In spite of this, "clinical guidelines for symptom control for patients with Covid-19" instructed NHS personnel to treat Covid-19 patients with excessive dosages of morphine and midazolam in order to relieve their symptoms.